JP Morgan Chase
CNMD icon

JP Morgan Chase’s CONMED CNMD Stock Holding History

JP Morgan Chase’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$5.48M – 7471
2023
Q4 		$5.48M Sell
50,000
-20,000
-29% -$2.07M ﹤0.01% 2998
2023
Q3 		$7.06M Buy
+70,000
New +$8.04M ﹤0.01% 2570
2022
Q1 		– Sell
-2,900
Closed -$411K – 6638
2021
Q4 		$411K Buy
+2,900
New +$411K ﹤0.01% 4953

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

JP Morgan Chase's CNMD Position: Q2 2026 in Review

JP Morgan Chase reduced its CONMED (CNMD) stake by 23% in Q2 2026, selling an estimated $434K and leaving 41,436 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #4413.

JP Morgan Chase first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $134M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • JP Morgan Chase held 41,436 shares of CONMED worth $1.47M as of Q2 2026.
  • JP Morgan Chase sold 12,045 CONMED shares in Q2 2026, an estimated $434K.
  • CONMED made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4413 holding.
  • JP Morgan Chase first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's CONMED position peaked at $134M in Q2 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.